CD27 as a Diagnostic Biomarker and Its Role in Immune Heterogeneity and Predicting Clinical Drug Responses in Hashimoto’s Thyroiditis
In our study, CD27 was found to contribute to predicting clinical outcomes in patients with HT, including disease status and response to immunotherapy. CD27 is a promising biomarker for HT microenvironment remodeling, offering insights into new therapeutic approaches to improve treatment of HT.
Authors
- Guo‐Qiang Bao (ORCID: https://orcid.org/0009-0005-6012-9177)
- Yanming Dong (ORCID: https://orcid.org/0000-0001-5756-5625)
Institutions
- Xi'an Medical University (CN)
Publication Details
- Journal
- Pharmacogenomics and Personalized Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.2147/pgpm.s487091
- Citations
- 1
- Primary Topic
- Salivary Gland Disorders and Functions
- Type
- article
- Field-Weighted Citation Impact
- 0.33